# Clinical Assessment of the Treatment With Cardiac Sympathetic Blockade on Chronic Heart Failure

> **NCT02391142** · NA · UNKNOWN · sponsor: **First Affiliated Hospital of Harbin Medical University** · enrollment: 100 (estimated)

## Conditions studied

- Heart Failure

## Interventions

- **DRUG:** Lidocaine

## Key facts

- **NCT ID:** NCT02391142
- **Lead sponsor:** First Affiliated Hospital of Harbin Medical University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-06
- **Primary completion:** 2018-12
- **Final completion:** 2019-01
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2018-08-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02391142

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02391142, "Clinical Assessment of the Treatment With Cardiac Sympathetic Blockade on Chronic Heart Failure". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02391142. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*